Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro - Wikidata - awgldk - TriplyDB

Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro

Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro

http://www.wikidata.org/entity/Q34959913

about

Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surface Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries Inhibition of Hepatitis C Virus Nonstructural Protein, Helicase Activity, and Viral Replication by a Recombinant Human Antibody Clone Bacteriophages and Their Immunological Applications against Infectious Threats.Expression and assembly of a fully active antibody in algae Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential.Human monoclonal antibody fragment specific for glycoprotein G in herpes simplex virus type 2 with applications for serotype-specific diagnosis.Construction of human Fab library and isolation of monoclonal Fabs with rabies virus-neutralizing ability.A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.Evaluation of CD4-CD4i antibody architectures yields potent, broadly cross-reactive anti-human immunodeficiency virus reagents.Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro.Localization of a passively transferred human recombinant monoclonal antibody to herpes simplex virus glycoprotein D to infected nerve fibers and sensory neurons in vivo.Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries Phage display on the base of filamentous bacteriophages: application for recombinant antibodies selection Biotechnological approaches to fight pathogens at mucosal sites.Human autoantibody recognition of DNA Production and characterization of a human recombinant monoclonal Fab fragment specific for influenza A viruses.Ocular distribution, spectrum of activity, and in vivo viral neutralization of a fully humanized anti-herpes simplex virus IgG Fab fragment following topical application In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?Protective immunity against hepatitis C virus infection.Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.Detection and typing of herpes simplex viruses by using recombinant immunoglobulin fragments produced in bacteria Engineering recombinant antibodies for immunotherapy.Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody Use of recombinant human antibody fragments for detection of cytomegalovirus antigenemia Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells.Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement.

P2860

Q24289014-663B91C7-793A-4105-B3A6-72218C82BFC6 Q26852060-BE626897-BBE8-4C9B-92A3-32E3D3090B39 Q27330259-AE7E4726-2241-49C0-8EA5-1D1ACA2B428E Q27469875-6B89426A-6073-47A7-A4A2-E52E86FBFCF1 Q27477552-190AB9A2-04E1-420C-99A0-BD10B0189734 Q30234522-6CB4BA56-5B58-4705-9DD5-37C199157F21 Q30880553-18FF713B-0694-4B2E-8BD3-388CDD8B5B0A Q31998570-01F6D59B-B20C-4742-B417-58BD1A077CB2 Q33198928-4625CCC4-BE1A-4551-BC73-EADF08A5B70F Q33214241-68444C30-9623-4709-B397-251DCDC55406 Q33285591-A1EE0EA1-5504-450E-A17B-A893891AE0DD Q33558696-485FD160-4903-4B66-A8BD-9DF5433201F7 Q33815811-046627F2-178E-4074-98AA-D5076D5F9931 Q33821358-BC22A84A-FA18-40D5-A9D1-D82900CDBB75 Q34127099-2BBD54ED-CCE2-4F4D-A3EE-48986D3646D0 Q34287677-37FD11FD-FA77-4B8E-83AA-AC57E7BA7F91 Q34351883-6785BC20-E358-4332-8872-C355C718CB2A Q34475971-3814DD0E-108C-4837-982E-F69060AC1363 Q35140153-7BFFEA28-315E-46BD-AB06-DC476A8BEDDD Q35806468-08707B64-AB38-47A9-8770-FCCA832545DD Q35874414-DE2A0E80-0676-4C27-A7DA-A75A39FFCBBA Q36023082-4E5F08C0-E4BA-446A-B109-304008C06508 Q36404194-27CE0901-9D75-491D-BF9E-7A52C1430E28 Q36410459-B20396CC-3C0D-4A2B-B0F9-E96FD9DA215A Q36432725-5BA94EEE-BB5B-4FDA-AB7B-495BC89B73AF Q36432748-3C46B24E-89DB-43B3-BE86-2A5091B7E7CE Q36544583-B1D0A04C-9CA0-4594-84E3-438ADEE8B52D Q36671887-C3FC3C3E-445D-484C-BA3D-E8367EFA2215 Q36799211-CCF37647-1542-40EF-A503-A7EDDD7FCE7B Q36872030-5B354270-0EB5-4467-B53F-F885DC54C7DF Q40810723-8D1A9EC8-C79E-45DB-9309-C11D13E1EEAC Q45740034-5C02D2D9-5F7B-4A00-B890-D69547E10D3D

P2860

Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro

http://www.wikidata.org/entity/Q34959913

description

1994 nî lūn-bûn

@nan

1994 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Recombinant human Fab to glyco ...... mplex viruses 1 and 2 in vitro

@en

Recombinant human Fab to glyco ...... mplex viruses 1 and 2 in vitro

@nl

type

label

Recombinant human Fab to glyco ...... mplex viruses 1 and 2 in vitro

@en

Recombinant human Fab to glyco ...... mplex viruses 1 and 2 in vitro

@nl

prefLabel

Recombinant human Fab to glyco ...... mplex viruses 1 and 2 in vitro

@en

Recombinant human Fab to glyco ...... mplex viruses 1 and 2 in vitro

@nl

P1433

Q34959913-CE41FE73-A563-44A0-B314-63D322D14B64

P1476

Q34959913-A1A23996-DB41-41A8-8F05-767B68EDA183

P2093

Q34959913-43195887-D6F0-42DF-8CFE-C88AE58D25BC

Q34959913-807DCB57-E4AE-408D-8A7B-EC78F5B25A7F

Q34959913-809690B4-9637-4E70-B138-474725E2852E

Q34959913-BB3CB01A-68AD-43C7-8555-3F7B66B38DE4

Q34959913-ED91D6EF-BE5C-4A65-BAB8-B977059219B3

P2860

Q34959913-0078A953-3644-4594-B179-D3A4860F7EC0

Q34959913-05D2A8FF-0C0F-493B-8318-1C877307F1BA

Q34959913-10D7DCA6-BD03-46FB-B53B-0DCE8E0E7FB5

Q34959913-1138C7CA-BDF9-4BB7-8815-2D2A898C8566

Q34959913-1F9A57F4-020D-44F6-AA7E-7AF8A01EF1D2

Q34959913-26F9FFC7-66F1-43B5-BACF-94515B7BE472

Q34959913-33E77BBE-89F8-4014-9363-7512D6AA6F86

Q34959913-41A60740-A5C4-49A7-AF0B-CDC0695F603C

Q34959913-5AD84858-92DA-4E51-BC6C-25A376450A32

Q34959913-7894B476-7086-4E43-9481-FDBD49702664

P304

Q34959913-96CC94F6-951A-4761-8CF6-976AD18F45CA

P31

Q34959913-77DC8ED8-EC70-44A8-9B44-5A3F6252E029

P356

Q34959913-DCDAD71D-4EAA-4BB8-B24E-0EB31C0D7B67

P407

Q34959913-E25F70B9-72FC-4A1F-9407-AFD397BE54EB

P433

Q34959913-321916AD-3F55-46F0-8D77-1CB72A4E323B

P478

Q34959913-49F310EB-EC1A-430F-9E65-D613689863FA

P577

Q34959913-918B07B1-C2C1-4704-A04B-E17970C7DEAC

P5875

Q34959913-74C1D3EE-B11D-41DB-BC4E-EAC121531A89

P698

Q34959913-6EBFC53F-3063-4248-9E84-8F30F67F5206

P932

Q34959913-0B0C0EE6-0BE9-4126-9A5A-175578A7EB99

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Recombinant human Fab to glyco ...... mplex viruses 1 and 2 in vitro

@en

P2093

D R Burton

http://www.w3.org/2001/XMLSchema#string

F E Bloom

http://www.w3.org/2001/XMLSchema#string

P P Sanna

http://www.w3.org/2001/XMLSchema#string

R A Williamson

http://www.w3.org/2001/XMLSchema#string

R Burioni

http://www.w3.org/2001/XMLSchema#string

P2860

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site

Phage antibodies: filamentous phage displaying antibody variable domains.

Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries.

Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.

Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease

The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy.

Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries.

Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture.

Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration

P304

355-359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.91.1.355

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

1994-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14921686

http://www.w3.org/2001/XMLSchema#string

P698

8278393

http://www.w3.org/2001/XMLSchema#string

P932

42946

http://www.w3.org/2001/XMLSchema#string